BioAdaptives Inc. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ae95303e-8cd9-427b-893d-0aa5cdcb2b3c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.6M | 2025-01-01 – 2025-12-31 | evidence 0001640334-26-000718 |
| FY 2024 | $-899.2k | 2024-01-01 – 2024-12-31 | evidence 0001640334-25-000660 |
| FY 2023 | $-712.5k | 2023-01-01 – 2023-12-31 | evidence 0001640334-24-000602 |
| FY 2022 | $-895.6k | 2022-01-01 – 2022-12-31 | evidence 0001640334-23-000532 |
| FY 2021 | $-1.0M | 2021-01-01 – 2021-12-31 | evidence 0001640334-22-000689 |
| FY 2020 | $-847.2k | 2020-01-01 – 2020-12-31 | evidence 0001640334-21-000706 |
| FY 2019 | $-238.9k | 2019-01-01 – 2019-12-31 | evidence 0001640334-20-000974 |
| FY 2018 | $-1.4M | 2018-01-01 – 2018-12-31 | evidence 0001640334-20-000974 |
| FY 2015 | $-227.4k | 2015-01-01 – 2015-12-31 | evidence 0001640334-16-000961 |
| FY 2014 | $-2.6M | 2014-01-01 – 2014-12-31 | evidence 0001262463-15-000273 |
| FY 2013 | $-26.7k | 2013-04-19 – 2014-03-31 | evidence 0001262463-14-000490 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).